# Dextromethorphan for Diabetic Macular Edema

> **NCT01441102** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 7 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Dextromethorphan hydrobromide

## Key facts

- **NCT ID:** NCT01441102
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-06
- **Final completion:** 2015-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441102, "Dextromethorphan for Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01441102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*